Obinutuzumab in Combination with Chlorambucil for Untreated Chronic Lymphocytic Leukaemia (TA343)

Ofatumumab in Combination with Chlorambucil or Bendamustine for Untreated Chronic Lymphocytic Leukaemia (TA344)

Bortezomib for Induction Therapy in Multiple Myeloma Before High-Dose Chemotherapy and Autologous Stem Cell Transplantation (TA311)

Afatinib for Treating Epidermal Growth Factor Receptor Mutation-Positive Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (TA310)

Pemetrexed Maintenance Treatment Following Induction Therapy with Pemetrexed and Cisplatin for Non-Squamous Non-Small-Cell Lung Cancer (TA309)

Bosutinib for Previously Treated Chronic Myeloid Leukaemia (TA299)

Crizotinib for Previously Treated Non-Small-Cell Lung Cancer Associated with an Anaplastic Lymphoma Kinase Fusion Gene (TA296)

Erlotinib for the First-Line Treatment of Locally Advanced or Metastatic EGFR-TK Mutation-Positive Non-Small-Cell Lung Cancer (TA258)

Erlotinib Monotherapy for Maintenance Treatment of Non-Small-Cell Lung Cancer (TA227)

Gefitinib for the First-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (TA192)